Analyst Price Targets — CARM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 11, 2024 6:33 am | Justin Zelin | BTIG | $6.00 | $1.91 | StreetInsider | BTIG Starts Carisma Therapeutics Inc (CARM) at Buy |
Latest News for CARM
Carmila: 2026 H1 Results
PARIS--(BUSINESS WIRE)--Regulatory News: Carmila (Paris:CARM): 2026 EPS1 guidance raised to €1.87 (from €1.84, vs €1.81 in 2025) Now expecting 3.3% EPS growth in 2026 Guidance upgrade driven by operating performance and Dijon Grand Quetigny acquisition Strong momentum across the three growth engines powered by asset transformation Organic growth: net rental income +1.4% (100 bps above indexation, continuing…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CARM.
U.S. House Trading
No House trades found for CARM.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.